Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are α-synucleinopathies

Parkinsonism and Related Disorders

Volumn 5, Issue 4, 1999, Pages 157-162

  Spillantini, M G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dementia with Lewy bodies; Multiple system atrophy; Parkinson's disease; synuclein; Synucleinopathies

Indexed keywords

ALPHA SYNUCLEIN;

ALZHEIMER DISEASE; DEMENTIA; HUMAN; LEWY BODY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SHY DRAGER SYNDROME;

EID: 0032867808     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(99)00031-0     Document Type: Article

References (62)

1. Duvoisin R.C. Familial Parkinson's disease. Neurosci News. 1:1998;43-46.
2. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
3. Braak H., Braak E., Yilmazer D., de Vos R.A.I., Jansen E.N.H., Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm. 103:1996;455-490.
4. Okazaki H., Lipkin L.E., Aronson S.M. Diffuse intracytoplasmic inclusions (Lewy type) associated with progressive dementia and quadraparesis in flexion. J Neuropathol Exp Neurol. 20:1961;237-244.
5. Hansen L.A., Salmon D., Galasko D., Masliah E., Katzman R., De Teresa R., Thal L., Pay M.M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 40:1990;1-8.
6. Lewy F.H. Paralysis agitans. I. Pathologische anatomie. Lewandowski M. Handbuch der Neurologie, Band III. 1912;920-933 Springer, Berlin.
7. Duffy P.E., Tennyson V.M. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's disease. J Neuropathol Exp Neurol. 24:1965;398-414.
8. Roy S., Wolman L. Ultrastructural observation in Parkinsonism. J Pathol. 99:1969;39-44.
9. Forno L.S. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol. 55:1996;259-272.
10. Goldman J.E., Yen S.H., Chiu F.C., Peress N.S. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science. 221:1983;1082-1084.
11. Kuzuhara S., Mori H., Izumiyama N., Yoshimura M., Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. 75:1988;345-353.
12. Golbe L.I., Di Iorio G., Bonavita V., Miller D.C., Duvoisin R.C. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol. 27:1990;276-282.
13. Polymeropoulos M.H., Higgins J.J., Golbe L.I., Johnson W.G., Ide S.E., Di Iorio G., Sanges G., Stenroos E.S., Pho L.T., Schaffer A.A., Lazzarini A.M., Nussbaum R.L., Duvoisin R.C. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science. 274:1996;1197-1199.
14. Polymeropoulos M., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
15. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18:1998;106-108.
16. Maroteaux L., Campanelli J.T., Scheller R.H. Synuclein: a neuron specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 8:1988;2804-2815.
17. Ueda K., Fukushima H., Masliah E., Xiay, Iwai A., Yoshimoto M., Otero D.A.C., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc Natl Acad Sci USA. 90:1993;11 282-11 286.
18. Jakes R., Spillantini M.G., Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett. 345:1994;27-32.
19. Tobe T., Nakajo S., Tanaka A., Mitoya A., Omata K., Tomita M., Nakamura Y. Cloning and characterization of the cDNA encoding a novel specific 14-kDa protein. J Neurochem. 59:1992;1624-1629.
20. Ji H., Liu Y.E., Jia T., Wang M., Liu J., Xiao G., Joseph B.K., Rosen C., Shi Y.E. Identification of a breast cancer-specific gene BCSGI, by direct differential cDNA sequencing. Cancer Res. 57:1997;759-764.
21. Akopian A.N., Wood J.N. Peripheral nervous system-specific genes identified by subtractive cDNA cloning. J Biol Chem. 270:1995;21 264-21 270.
22. Buchman V.L., Adu J., Pinõn L.G.P., Ninkina N.N., Davies A.M. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nature Neurosci. 1:1998;101-103.
23. Ninkina N.N., Alimova-Kost M.V., Paterson L., Delaney B.B., Cohen S., Imreh S., Gnuchev A.M., Davies A.M., Buchman V.L. Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet. 7:1998;1417-1424.
24. Lavedan C., Leroy E., Anindya D., Buchholtz S., Dutra A., Nussbaum R., Polymeropoulos M.H. Identification, localization and characterization of the human γ-synuclein gene. Hum Genet. 103:1998;106-112.
25. Chen X., De Silva R.H.A., Pettenati M.J., Rao P.N., George-Hyslop P., Roses A.D., Xia Y., Horsburg K., Ueda K., Saitoh T. The human NACP/α-synuclein gene: chromosome assignment to 4q21.3-q22 and Taq I RFLP analysis. Genomics. 26:1995;425-427.
26. Spillantini M.G., Divane A., Goedert M. Assignment of human α-synuclein (SNCA) and β-synuclein (SNCB) genes to chromosome 4q21 and 5q35. Genomics. 27:1995;379-381.
27. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21:1998;225-271.
28. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., De Silva R.H.A., Kittel A., Saitoh T. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14:1995;467-475.
29. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., Lansbury P.T. NACP, a protein implicated in Alzheimer's disease and learning is natively unfolded. Biochemistry. 35:1996;13 709-13 715.
30. Davidson W.S., Jonas A., Clayton D.F., George J.M. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 273:1998;9443-9449.
31. George J.M., Jin H., Woods W.S., Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron. 15:1995;361-372.
32. Jensen P.H., Nielsen M.S., Jakes R., Dotti C.G., Goedert M. Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem. 273:1995;26 292-26 294.
33. Iwai A., Yoshimoto M., Masliah E., Saitoh T. Non-Aβ component of Alzheimer's disease amyloid plaques (NAC) is amyloidogenic. Biochemistry. 34:1995;10 139-10 145.
34. Han H., Weinreb P.H., Lansbury P.T. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol Chem Biol Interact. 2:1995;163-169.
35. Jensen P.H., Hojrup P., Hager H., Nielsen M.S., Jacobsen L., Olesen O.F., Gliemann J., Jakes R. Binding of Aβ to α- and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC. Biochem J. 323:1997;539-546.
36. Spillantini M.G., Schmidt M.L., Lee V.-M.Y., Trojanowski J.Q., Jakes R., Goedert M. α-Synuclein in Lewy bodies. Nature. 388:1997;839-840.
37. Lennox G., Lowe J., Landon M., Mayer R.J. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiat. 52:1989;67-71.
38. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA. 95:1998;6469-6473.
39. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett. 239:1997;45-48.
40. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol. 152:1998;367-372.
41. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M.Y., Trojanowski J.Q., Iwatsubo T. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol. 152:1998;879-884.
42. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol. 57:1998;334-337.
43. Mezey E., Dehejia A.M., Harta G., Suchy S.F., Nussbaum R.L., Brownstein M.J. Alpha-synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol Psychiat. 3:1998;493-499.
44. Hulette C., Mirra S., Wilkinson W., Heyman A., Fillenbaum G., Clark C. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 45:1995;1991-1995.
45. Raghavan R., Khin-Nu C., Brown A., Irving D., Ince P.G., Day P., Tyrer S.P., Perry R.H. Detection of Lewy bodies in trisomy 21 (Down's syndrome). Can J Neurol Sci. 20:1993;48-51.
46. Piccardo P., Mirra S.S., Young K., Gearing M., Dlouhy S.R., Ghetti B. α-Synuclein accumulation in Gerstmann-Sträussler-Scheinker disease (GSS) with prion protein gene (PRNP) mutation F198S. Neurobiol Aging. 19:1998;S172.
47. Lippa C.F., Fujiwara H., Mann D.M.A., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St George-Hyslop P., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.-M.Y., Iwatsubo T., Trojanowski J.Q. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol. 153:1998;1365-1370.
48. Spillantini M.G., Tolnay M., Love S., Goedert M. Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol. 97:1999;585-594.
49. Papp M.I., Khan J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy. J Neurol Sci. 94:1989;79-100.
50. Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett. 249:1998;180-182.
51. Mezey E., Dehejia A., Harta G., Papp N.I., Polymeropoulos M.H., Brownstein M.J. Alpha synuclein in neurodegenerative disorders: murder or accomplice? Nature Med. 4:1998;755-757.
52. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett. 251:1998;205-208.
53. Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M., Takahashi H. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 96:1998;445-452.
54. Gai W.P., Power J.H.T., Blumbergs P.C., Blessing W.W. Multiple system atrophy: a new α-synuclein disease? The Lancet. 352:1998;547-548.
55. Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., Kawai M. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 96:1998;439-444.
56. Tu P., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J.Q., Lee V.M.Y. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol. 44:1998;415-422.
57. Lantos P.T. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol. 57:1998;1099-1111.
58. Arawaka S., Saito Y., Murayama S., Mori H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein. Neurology. 51:1998;887-889.
59. Crowther R.A., Jakes R., Spillantini M.G., Goedert M. Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett. 436:1998;309-312.
60. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson's disease. Nat Med. 4:1998;1318-1320.
61. Hashimoto M., Hsu L.J., Sisk A., Xia Y., Takeda A., Sundsmo M., Masliah E. Human recombinant NACP/α-syncuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 799:1998;301-306.
62. Goedert M., Spillantini M.G. Lewy body diseases and multiple system atrophy as α-synucleinopathies. Mol Psychiat. 3:1998;462-465.